Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Neurobiology of Learning and Memory
|
January 10, 2013
Low-frequency stimulation of the ventral hippocampus facilitates extinction of contextual fear
Carine Cleren, Isabelle Tallarida, Emilie Le Guiniec, et al.
Therapeutic Advances in Urology
|
December 22, 2018
Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy
Thierry Lebret, Alain Ruffion, Igor Latorzeff, et al.
Journal of Medicinal Chemistry
|
February 6, 2015
Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach
Hasane Ratni, Mark Rogers-Evans, Caterina Bissantz, et al.
Psychopharmacology
|
February 19, 2005
Neuropeptide expression in rats exposed to chronic mild stresses
Valeriy Sergeyev, Serguei Fetissov, Aleksander A Mathé, et al.
Plos One
|
July 7, 2012
Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone
Stephen R Morairty, Florent G Revel, Pari Malherbe, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2003
[Prostate cancer screening]
Arnauld Villers, Xavier Rébillard, Michel Soulié, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
March 1, 2014
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study
Thierry Lebret, Stéphane Culine, Jean-Louis Davin, et al.
Therapeutic Advances in Urology
|
December 2, 2014
Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study
Thierry Lebret, Jean-Louis Davin, Christophe Hennequin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 23, 2011
fMRI fingerprint of unconditioned fear-like behavior in rats exposed to trimethylthiazoline
Melanie S Kessler, Sébastien Debilly, Stephanie Schöppenthau, et al.
Neuropharmacology
|
December 6, 2011
Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia
Daniela Alberati, Jean-Luc Moreau, Judith Lengyel, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Neurobiology of Learning and Memory
|
January 10, 2013
Low-frequency stimulation of the ventral hippocampus facilitates extinction of contextual fear
Carine Cleren, Isabelle Tallarida, Emilie Le Guiniec, et al.
Therapeutic Advances in Urology
|
December 22, 2018
Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy
Thierry Lebret, Alain Ruffion, Igor Latorzeff, et al.
Journal of Medicinal Chemistry
|
February 6, 2015
Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach
Hasane Ratni, Mark Rogers-Evans, Caterina Bissantz, et al.
Psychopharmacology
|
February 19, 2005
Neuropeptide expression in rats exposed to chronic mild stresses
Valeriy Sergeyev, Serguei Fetissov, Aleksander A Mathé, et al.
Plos One
|
July 7, 2012
Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone
Stephen R Morairty, Florent G Revel, Pari Malherbe, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2003
[Prostate cancer screening]
Arnauld Villers, Xavier Rébillard, Michel Soulié, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
March 1, 2014
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study
Thierry Lebret, Stéphane Culine, Jean-Louis Davin, et al.
Therapeutic Advances in Urology
|
December 2, 2014
Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study
Thierry Lebret, Jean-Louis Davin, Christophe Hennequin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 23, 2011
fMRI fingerprint of unconditioned fear-like behavior in rats exposed to trimethylthiazoline
Melanie S Kessler, Sébastien Debilly, Stephanie Schöppenthau, et al.
Neuropharmacology
|
December 6, 2011
Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia
Daniela Alberati, Jean-Luc Moreau, Judith Lengyel, et al.
Page
of 6